The Australian medical cannabis company, MMJ PhytoTech Limited, has released medical cannabis pills, but for now they’re only available in Europe.

Each capsule contains 10 milligrams of cannabidiol (CBD) and zero tetrahydrocannabinol (THC). The medication costs 89 euros, or $133 (CDN).

Registered as a dietary supplement in Germany, CBD has been shown to help patients suffering from cancer, anxiety and epilepsy.

The cannabis grown for the pills was done so without herbicides or pesticides, according to the company’s website, in a process called “Farm to Pharma.”

“August was a month of ‘firsts’ for the Company … our first clinical study was approved, the first CBD Capsules were available on our new online direct sales platform and the Company’s first revenues were generated,” Andreas Gedeon, CEO and Managing Director of MMJ, said in a statement. “These achievements represent the progress we have made as a company in the implementation of our ‘Farm to Pharma’ strategy that will see our operations spanning the entire medical cannabis value chain.”

Medical cannabis is still illegal in Australia, despite polls finding an overwhelming majority support the medication for the sick. Yet despite its illegality down-under, the government has licensed medical cannabis companies, like AusCann, to grow on Norfolk Island and then export it to Canada.

Footnote(s)